Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Psychopharmacology (Berl). 2013 Jul 7;230(4):10.1007/s00213-013-3198-2. doi: 10.1007/s00213-013-3198-2

Table 1. Baseline and follow-up demographic characteristics.

Controls (n = 20) M (SD) Heavy Drinkers (n = 20) M (SD)
Baseline Age (range 11.7 to 16.7) 14.1 (1.2) 14.7 (1.1)
% female 45% 45%
Hollingshead SESa 26.2 (18.0) 24.1 (17.9)
Family history density 0.8 (0.8) 0.8 (0.8)
Achenbach Externalizing T-score 39.8 (6.6) 43.1 (8.3)
Achenbach Internalizing T-score 38.5 (9.3) 42.3 (10.7)
Reading standard score 110.1 (13.0) 113.0 (6.2)
Vocabulary T-score 53.7 (11.8) 58.3 (6.5)
Pubertal stage 2.6 (0.6) 2.9 (0.6)
Body mass index 21.0 (5.2) 20.2 (2.8)
Inhibitions percent correct (%) 77.4 (1.1) 83.3 (1.1)
D-prime (D′) 3.1 (0.6) 3.1 (0.5)
Response bias (β) 0.2 (0.2) 0.2 (0.1)
Follow-up Age (range 14.7 to 20.6) 17.6 (1.2) 18.5 (1.8)
Years between baseline and follow-up 3.4 (0.8) 3.3 (1.2)
Achenbach Externalizing T-score 37.6 (3.9) 41.6 (13.0)
Achenbach Internalizing T-score 34.8 (7.2) 38.9 (11.4)
Past year drinking days per month*** 0.0 (0.1) 2.8 (1.8)
Past year average drinks/episode*** 0.2 (0.4) 4.2 (2.1)
Past year bingeb episodes*** 0.0 (0.0) 9.0 (13.8)
Past year peak drinks/episode*** 0.0 (0.0) 10.5 (11.3)
Lifetime number of drinks*** 0.5 (0.9) 92.3 (94.5)
Lifetime number of cigarettes*** 0.0 (0.0) 0.5 (0.2)
Lifetime cannabis use episodes* 0.3 (1.1) 4.8 (9.1)
Lifetime other drug use episodes*** 0.0 (0.0) 0.2 (0.5)
Days since last alcohol binge episodec N/A 70
Days since last cannabis usec 138 116
Days since last other drug usec N/A 131
Inhibitions percent correct (%) 86.4 (1.0) 90.6 (0.7)
D-prime (D′) 3.3 (1.0) 3.8 (0.5)
Response bias (β) 0.2 (0.1) 0.3 (0.1)
*

p < 0.05

**

p < 0.01

***

p < 0.001

a

Hollingshead SES scores typically range from 11-77, with lower scores indicating higher SES.

b

Binge episode = 4+ drinks for females or 5+ drinks for males.

c

Of those individuals who reported alcohol, cannabis, and/or other drug use, average number of days between date of last use and scan date.